Clinical Trial

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

Study acronym: HBOTpCOVID
Recruiting
View on ClinicalTrials.gov →
Summary
Post-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more. This long-term sequela can last for months after recovering from the virus, and no treatment is known to date. The aim of this study is to compare the effect of HBOT vs. Sham on post COVID-19 syndrome
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-11-29; most recent amendment 2026-04-16.
Status change: Completed → Recruiting 2026-04-16
Status change: Not Yet Recruiting → Completed 2022-01-12
Trial Details
NCT Number NCT04647656
Lead Sponsor Assaf-Harofeh Medical Center
Conditions Covid19, Neurocognitive Dysfunction
Enrollment 91 participants
Start Date 2023-06-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-21